Filing Flows › Companies › Aurinia Pharmaceuticals › Earnings quality
Aurinia Pharmaceuticals earnings quality score
How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show
Score44 / 100 · grade D · rank 938 of 1027
Aurinia Pharmaceuticals (AUPH) scores 44 of 100 for earnings quality, grade D: rank 938 of 1027 companies and 116 of 126 in health. It loses the most points on accruals of +23.3% of assets, higher than 99% of companies (profit running ahead of cash), discretionary accruals of +10.2% of assets (modified Jones), larger than most, Montier C-score 3 of 5 checks failed. It earns full or near-full marks for Piotroski F-score 8 of 9, adjusted earnings 1% below GAAP, profit about as variable as cash flow (smoothness 1.61).
What earned and lost points
| Component | What the filings show | Points | Of |
|---|---|---|---|
| Accruals | accruals of +23.3% of assets, higher than 99% of companies (profit running ahead of cash) | 0 | 29 |
| Montier C-score | Montier C-score 3 of 5 checks failed | 9 | 21 |
| Discretionary accruals | discretionary accruals of +10.2% of assets (modified Jones), larger than most | 2 | 14 |
| Piotroski F-score | Piotroski F-score 8 of 9 | 13 | 14 |
| Non-GAAP gap | adjusted earnings 1% below GAAP | 14 | 14 |
| Earnings smoothness | profit about as variable as cash flow (smoothness 1.61) | 7 | 7 |
How the score is built
Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.
Every company ranked → The full quality workbench, live → Aurinia Pharmaceuticals: cash flow →
Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.